logo
Who should receive hepatitis A vaccine?
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares
Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-α in combination with ribavirin and amantadine
Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon
High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy
Interferon α in the treatment of chronic hepatitis C in children
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients
Aetiology and prognostic factors in acute liver failure in India
Alarming prevalence of hepatitis-B infection among the Jarawas – a primitive Negrito tribe of Andaman and Nicobar Islands, India
Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules